首页 > 最新文献

Iranian Journal of Pathology最新文献

英文 中文
Activity Assessment of Antibiotics Used Against Different Bacterial Etiological Agents of UTI in Najaf, Iraq. 伊拉克纳杰夫地区针对不同细菌性尿路感染病原体所使用抗生素的活性评估。
Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-08-09 DOI: 10.30699/ijp.2024.2027209.3293
Mohammed Jasim Al-Shamarti

Background & objective: Antibiotic resistance in urinary tract infection (UTI) is increasing nowadays, therefore, the aim of this study was to evaluate the resistance patterns of many pathogens toward several antibiotics that are in common use in our hospitals.

Methods: Subculture and identification of pathogenic bacteria were performed on 1148 hospitals' bacterial primary cultures which were considered positive for UTI. An antibiotic sensitivity test was performed by using the disc diffusion method. The rates of resistance were statistically analyzed and correlated with the types of antibiotics and bacteria.

Results: It was found that 1148 out of 2087 urine samples were UTI positive, the majority of cases (76%) were from females (P<0.0001). Escherichia coli and Klebsiella were the most isolated Gram-negative bacteria, while Staphylococcus spp. was the most isolated Gram-positive pathogen. E. coli showed the highest resistance rate among all bacteria, while Streptococcus spp. was the most sensitive. The highest resistance was noticed to be against gentamicin and ampicillin, while the most effective drugs were imipenem and amikacin. There was a significant difference in resistance rates among the different bacterial categories (P<0.0001), while no significant difference was noticed in resistance rates among antibiotics categories (P>0.05).

Conclusion: Elevated rates of antibiotic resistance were noticed in this study in UTI-causing bacteria; therefore, it is highly important at least to every general hospital to investigate the antibiotic resistance rates occasionally to determine the proper antimicrobial treatment as well as re-evaluate antibiotics which were considered as empirical.

背景与目的:尿路感染(UTI)的耐药性日益增加,因此,本研究的目的是评估多种病原菌对我院常用几种抗生素的耐药模式。方法:对医院1148例尿路感染阳性的细菌原代培养进行传代培养和病原菌鉴定。采用圆盘扩散法进行抗生素敏感性试验。对耐药率进行统计分析,并与抗生素和细菌种类相关。结果:2087份尿样中检出尿路感染阳性1148例,以女性居多(76%)(革兰氏阴性菌以大肠杆菌和克雷伯氏菌最多,革兰氏阳性菌以葡萄球菌最多)。大肠杆菌耐药率最高,链球菌最敏感。对庆大霉素和氨苄西林的耐药性最高,对亚胺培南和阿米卡星的耐药性最强。不同菌种间耐药率差异有统计学意义(p < 0.05)。结论:本研究发现引起尿路感染的细菌中抗生素耐药率升高;因此,至少对每家综合医院来说,偶尔调查抗生素耐药率以确定适当的抗菌药物治疗以及重新评估被认为是经验性的抗生素是非常重要的。
{"title":"Activity Assessment of Antibiotics Used Against Different Bacterial Etiological Agents of UTI in Najaf, Iraq.","authors":"Mohammed Jasim Al-Shamarti","doi":"10.30699/ijp.2024.2027209.3293","DOIUrl":"10.30699/ijp.2024.2027209.3293","url":null,"abstract":"<p><strong>Background & objective: </strong>Antibiotic resistance in urinary tract infection (UTI) is increasing nowadays, therefore, the aim of this study was to evaluate the resistance patterns of many pathogens toward several antibiotics that are in common use in our hospitals.</p><p><strong>Methods: </strong>Subculture and identification of pathogenic bacteria were performed on 1148 hospitals' bacterial primary cultures which were considered positive for UTI. An antibiotic sensitivity test was performed by using the disc diffusion method. The rates of resistance were statistically analyzed and correlated with the types of antibiotics and bacteria.</p><p><strong>Results: </strong>It was found that 1148 out of 2087 urine samples were UTI positive, the majority of cases (76%) were from females (<i>P</i><0.0001). <i>Escherichia coli</i> and <i>Klebsiella</i> were the most isolated Gram-negative bacteria, while Staphylococcus spp. was the most isolated Gram-positive pathogen. E. coli showed the highest resistance rate among all bacteria, while Streptococcus spp. was the most sensitive. The highest resistance was noticed to be against gentamicin and ampicillin, while the most effective drugs were imipenem and amikacin. There was a significant difference in resistance rates among the different bacterial categories (<i>P</i><0.0001), while no significant difference was noticed in resistance rates among antibiotics categories (<i>P</i>>0.05).</p><p><strong>Conclusion: </strong>Elevated rates of antibiotic resistance were noticed in this study in UTI-causing bacteria; therefore, it is highly important at least to every general hospital to investigate the antibiotic resistance rates occasionally to determine the proper antimicrobial treatment as well as re-evaluate antibiotics which were considered as empirical.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 3","pages":"348-354"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11646199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142839401","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Histopathologic and Prognostic Significance of Tumor Budding in Colorectal Adenocarcinoma: A Retrospective Cohort Study Conducted in Shiraz, Iran. 结直肠腺癌肿瘤发生的组织病理学和预后意义:在伊朗设拉子进行的一项回顾性队列研究。
Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2021-12-15 DOI: 10.30699/IJP.2023.1999329.3090
Mohammad Hossein Anbardar, Nadia Rahimizadeh

Background & objective: Colorectal cancer is the second reason for cancer-associated death. The prognosis of the malignancy is defined by TNM scoring. However, tumor grading, lymphovascular invasion, perineural invasion, and tumor buddings may affect its prognosis. This study aimed to assess the prognostic and histologic impact of tumor budding in colorectal adenocarcinoma.

Methods: This study is a retrospective cohort of 192 patients with colorectal adenocarcinoma. All four stages of colorectal adenocarcinoma patients were included, but the patients in stages I and II were also analyzed separately. We used pathology reports to extract the histopathologic data. The prognostic values were extracted by calling the patients.

Results: Less than half of the patients were in stages I and II of the disease. According to our analysis, tumor extension and lymphovascular invasion were correlated with tumor budding count in patients in stages I and II, and lymphovascular invasion, tumor grade, tumor stage, lymph node involvement, tumor extension, tumor site, metastasis, and five-year survival were correlated with tumor budding within all stages.

Conclusion: It is recommended that tumor budding count should be assessed and reported in pathology reports of adenocarcinomas due to its high correlation with poor prognosis.

背景与目的:结直肠癌是癌症相关死亡的第二大原因。恶性肿瘤的预后由 TNM 评分确定。然而,肿瘤分级、淋巴管侵犯、神经周围侵犯和肿瘤萌芽可能会影响其预后。本研究旨在评估肿瘤出芽对结直肠腺癌预后和组织学的影响:本研究是一项回顾性队列研究,共纳入 192 名结直肠腺癌患者。所有四期结直肠腺癌患者均包括在内,但也对 I 期和 II 期患者进行了单独分析。我们使用病理报告来提取组织病理学数据。我们通过呼叫患者来提取预后值:结果:不到一半的患者处于疾病的 I 期和 II 期。根据我们的分析,Ⅰ期和Ⅱ期患者的肿瘤扩展和淋巴管侵犯与肿瘤出芽数相关,而各期患者的淋巴管侵犯、肿瘤分级、肿瘤分期、淋巴结受累、肿瘤扩展、肿瘤部位、转移和五年生存率与肿瘤出芽数相关:建议在腺癌病理报告中评估和报告肿瘤出芽数,因为它与不良预后高度相关。
{"title":"Histopathologic and Prognostic Significance of Tumor Budding in Colorectal Adenocarcinoma: A Retrospective Cohort Study Conducted in Shiraz, Iran.","authors":"Mohammad Hossein Anbardar, Nadia Rahimizadeh","doi":"10.30699/IJP.2023.1999329.3090","DOIUrl":"10.30699/IJP.2023.1999329.3090","url":null,"abstract":"<p><strong>Background & objective: </strong>Colorectal cancer is the second reason for cancer-associated death. The prognosis of the malignancy is defined by TNM scoring. However, tumor grading, lymphovascular invasion, perineural invasion, and tumor buddings may affect its prognosis. This study aimed to assess the prognostic and histologic impact of tumor budding in colorectal adenocarcinoma.</p><p><strong>Methods: </strong>This study is a retrospective cohort of 192 patients with colorectal adenocarcinoma. All four stages of colorectal adenocarcinoma patients were included, but the patients in stages I and II were also analyzed separately. We used pathology reports to extract the histopathologic data. The prognostic values were extracted by calling the patients.</p><p><strong>Results: </strong>Less than half of the patients were in stages I and II of the disease. According to our analysis, tumor extension and lymphovascular invasion were correlated with tumor budding count in patients in stages I and II, and lymphovascular invasion, tumor grade, tumor stage, lymph node involvement, tumor extension, tumor site, metastasis, and five-year survival were correlated with tumor budding within all stages.</p><p><strong>Conclusion: </strong>It is recommended that tumor budding count should be assessed and reported in pathology reports of adenocarcinomas due to its high correlation with poor prognosis.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 1","pages":"59-66"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11164312/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307057","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Current Understanding of PCSK9 and Its Relevance to Cancer Prognosis and Immune Therapy: A Review. 目前对 PCSK9 及其与癌症预后和免疫疗法相关性的了解:综述。
Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2023-12-29 DOI: 10.30699/IJP.2023.1999459.3093
Morteza Hassandokht Mashhadi, Fahime Taheri, Sadaf Irani, Arshiya Mesbah Mousavi, Ali Mehri, Hossein Javid

The effectiveness of immunotherapy for most cancer patients remains low, with approximately 10-30% of those treated surviving. Thus, much effort is being put into finding new ways to improve immune checkpoint therapy. Our review concludes that inhibition of proprotein convertase subtilisin/Kexin type 9 (PCSK9), which plays a critical role in regulating cholesterol metabolism, can cause movement of T cells toward tumors, with increased sensitivity to immune checkpoint therapies. We searched PubMed, NCBI, Scopus, and Google Scholar for the published articles without limitations on publication dates. We used the following terms: "PCSK9", "Cancer", "Immune Checkpoint", and "Cancer Prognosis" in the title and/or abstract. Our search initially revealed 600 records on the subject and stored them in the used databases under EndNote X8 management software. A total of 161 articles were selected and through a careful review, 76 were included in our research. We concluded that PCSK9 reduces the number of LDL receptors (LDL-R) on the cell surface, which is linked to its ability to regulate cholesterol levels in the body. Also, we discuss how suppressing PCSK9 leads to the MHC-1 accumulation on the surface of cancer cells, which results in T lymphocyte invasion. Finally, we believe that inhibiting PCSK9 may be an effective strategy for improving cancer immunotherapy.

免疫疗法对大多数癌症患者的疗效仍然很低,大约只有 10-30% 的患者能够存活。因此,人们正在努力寻找改进免疫检查点疗法的新方法。我们的综述得出结论,抑制在调节胆固醇代谢中发挥关键作用的9型潜血蛋白酶/Kexin(PCSK9)可导致T细胞向肿瘤移动,从而提高对免疫检查点疗法的敏感性。我们检索了 PubMed、NCBI、Scopus 和 Google Scholar 上发表的文章,对发表日期没有限制。我们使用了以下术语:标题和/或摘要中包含 "PCSK9"、"癌症"、"免疫检查点 "和 "癌症预后"。我们的搜索初步发现了 600 条相关记录,并将其存储在 EndNote X8 管理软件下的数据库中。共筛选出 161 篇文章,经过仔细审阅,76 篇文章被纳入我们的研究。我们的结论是,PCSK9 可减少细胞表面低密度脂蛋白受体(LDL-R)的数量,这与其调节体内胆固醇水平的能力有关。此外,我们还讨论了抑制 PCSK9 如何导致癌细胞表面的 MHC-1 积累,从而导致 T 淋巴细胞入侵。最后,我们认为抑制 PCSK9 可能是改善癌症免疫疗法的有效策略。
{"title":"Current Understanding of PCSK9 and Its Relevance to Cancer Prognosis and Immune Therapy: A Review.","authors":"Morteza Hassandokht Mashhadi, Fahime Taheri, Sadaf Irani, Arshiya Mesbah Mousavi, Ali Mehri, Hossein Javid","doi":"10.30699/IJP.2023.1999459.3093","DOIUrl":"10.30699/IJP.2023.1999459.3093","url":null,"abstract":"<p><p>The effectiveness of immunotherapy for most cancer patients remains low, with approximately 10-30% of those treated surviving. Thus, much effort is being put into finding new ways to improve immune checkpoint therapy. Our review concludes that inhibition of proprotein convertase subtilisin/Kexin type 9 (PCSK9), which plays a critical role in regulating cholesterol metabolism, can cause movement of T cells toward tumors, with increased sensitivity to immune checkpoint therapies. We searched PubMed, NCBI, Scopus, and Google Scholar for the published articles without limitations on publication dates. We used the following terms: \"PCSK9\", \"Cancer\", \"Immune Checkpoint\", and \"Cancer Prognosis\" in the title and/or abstract. Our search initially revealed 600 records on the subject and stored them in the used databases under EndNote X8 management software. A total of 161 articles were selected and through a careful review, 76 were included in our research. We concluded that PCSK9 reduces the number of LDL receptors (LDL-R) on the cell surface, which is linked to its ability to regulate cholesterol levels in the body. Also, we discuss how suppressing PCSK9 leads to the MHC-1 accumulation on the surface of cancer cells, which results in T lymphocyte invasion. Finally, we believe that inhibiting PCSK9 may be an effective strategy for improving cancer immunotherapy.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 1","pages":"1-9"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11164309/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141307788","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Rare Malignancy of the Eyelid: Report A Case of Primary Periocular Histiocytoid Carcinoma. 罕见的眼睑恶性肿瘤:报告一例原发性眼周组织细胞样癌。
Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-07-24 DOI: 10.30699/IJP.2024.2016655.3219
Arezu Rahnavard, Elham Mirzaian, Reyhaneh Safaei, Ida Mehrabi

Primary periocular histiocytoid carcinoma is a very rare malignant tumor. Until now, less than 50 cases have been reported in the English literature. It is characterized by resistant epiphora, limitation in extraocular motility, and ptosis. The definitive diagnosis of this lesion is made based on detecting histological histiocytoid features along with tracing positivity of specific biomarkers using immunohistochemistry. However, pathologists may be faced with two major obstacles in the diagnosis of this tumor including distinguishing it from metastatic histiocytoid lesions and also from benign mimics such as reactive inflammatory lesions. Here, we describe a case of primary periocular histiocytoid carcinoma located on the eyelid as well as review the literature to clarify the histopathological and diagnostic features of this tumor.

摘要原发性眼周组织细胞样癌是一种非常罕见的恶性肿瘤。到目前为止,在英语文献中报道的病例不到50例。它的特点是抵抗性上睑下垂、眼外运动受限和上睑下垂。这种病变的明确诊断是基于检测组织学组织细胞样特征以及使用免疫组织化学追踪特定生物标志物的阳性。然而,病理学家在诊断这种肿瘤时可能面临两个主要障碍,包括将其与转移性组织细胞样病变以及良性模拟病变(如反应性炎症病变)区分开来。在此,我们报告一例位于眼睑的原发性眼周组织细胞样癌,并回顾文献以阐明该肿瘤的组织病理学和诊断特征。
{"title":"A Rare Malignancy of the Eyelid: Report A Case of Primary Periocular Histiocytoid Carcinoma.","authors":"Arezu Rahnavard, Elham Mirzaian, Reyhaneh Safaei, Ida Mehrabi","doi":"10.30699/IJP.2024.2016655.3219","DOIUrl":"10.30699/IJP.2024.2016655.3219","url":null,"abstract":"<p><p>Primary periocular histiocytoid carcinoma is a very rare malignant tumor. Until now, less than 50 cases have been reported in the English literature. It is characterized by resistant epiphora, limitation in extraocular motility, and ptosis. The definitive diagnosis of this lesion is made based on detecting histological histiocytoid features along with tracing positivity of specific biomarkers using immunohistochemistry. However, pathologists may be faced with two major obstacles in the diagnosis of this tumor including distinguishing it from metastatic histiocytoid lesions and also from benign mimics such as reactive inflammatory lesions. Here, we describe a case of primary periocular histiocytoid carcinoma located on the eyelid as well as review the literature to clarify the histopathological and diagnostic features of this tumor.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 3","pages":"359-362"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11646197/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142839476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparison of the Structural, Cytological and Biomarker Expression in Carcinoma in situ and Invasive Components in Breast Carcinoma. 乳腺癌原位癌和浸润性成分结构、细胞学和生物标志物表达的比较。
Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-04-07 DOI: 10.30699/IJP.2024.2025907.3285
Azar Naimi, Niloufar Mohaghegh

Background & objective: Breast cancer is thought to arise from non-invasive breast lesions, such as atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS). DCIS is considered a direct precursor of invasive carcinoma. The morphological features alone do not reflect the biological truth of this disease. Therefore, we investigated features of carcinoma in situ and the invasive components in women diagnosed with breast cancer.

Methods: This study was a cross-sectional study. The corresponding IHC slides were selected from the pathology archive and examined by the pathologist. Fifty-one samples which showed both in situ and invasive components confirmed immunohistochemically, were included in the study.

Results: In 70.6% of the cases a high grade of in situ and invasive carcinoma was observed. In 45.1% of the studied cases, a solid structure was observed in in-situ carcinoma, and no otherwise specified structure was observed in invasive carcinoma. In 74.5% of both in situ and invasive carcinoma types, ER.PR had a positive value. In 45.5% of the cases, both in situ and invasive carcinoma components show low Ki67. In 42.2%, both in situ and invasive carcinomas were Her2 negative. There was no significant difference between the grade (P=0.687), Her2 type (P=0.532), and structure (P=0.532). ER.PR (P=1.00) and Ki67 (P=0.180) of in situ and invasive carcinoma in this study.

Conclusion: Our study showed differences between in situ and invasive biomarker expression. According to our findings, owing to heterogeneity, in situ components can't be representative of invasive components for treatment choices.

背景与目的:乳腺癌被认为是由非侵入性乳腺病变引起的,如非典型导管增生(ADH)和导管原位癌(DCIS)。DCIS 被认为是浸润性癌的直接前兆。单从形态学特征来看,并不能反映这种疾病的生物学真相。因此,我们对确诊为乳腺癌的女性中原位癌和浸润癌的特征进行了调查:本研究为横断面研究。从病理档案中选取相应的 IHC 切片,由病理学家进行检查。结果:70.6%的病例中存在原位癌和浸润癌:在 70.6% 的病例中观察到了高级别原位癌和浸润癌。45.1%的研究病例在原位癌中观察到实体结构,在浸润癌中未观察到其他特殊结构。在 74.5%的原位癌和浸润癌中,ER.PR 均为阳性。在 45.5%的病例中,原位癌和浸润癌的 Ki67 值都很低。42.2%的原位癌和浸润癌均为 Her2 阴性。等级(P=0.687)、Her2 类型(P=0.532)和结构(P=0.532)之间无明显差异。本研究中原位癌和浸润癌的ER.PR(P=1.00)和Ki67(P=0.180)均无明显差异:我们的研究显示了原位癌和浸润癌生物标志物表达的差异。结论:我们的研究表明,原位癌和浸润癌的生物标志物表达存在差异。根据我们的研究结果,由于异质性,原位癌不能代表浸润癌的治疗选择。
{"title":"Comparison of the Structural, Cytological and Biomarker Expression in Carcinoma in situ and Invasive Components in Breast Carcinoma.","authors":"Azar Naimi, Niloufar Mohaghegh","doi":"10.30699/IJP.2024.2025907.3285","DOIUrl":"10.30699/IJP.2024.2025907.3285","url":null,"abstract":"<p><strong>Background & objective: </strong>Breast cancer is thought to arise from non-invasive breast lesions, such as atypical ductal hyperplasia (ADH) and ductal carcinoma in situ (DCIS). DCIS is considered a direct precursor of invasive carcinoma. The morphological features alone do not reflect the biological truth of this disease. Therefore, we investigated features of carcinoma in situ and the invasive components in women diagnosed with breast cancer.</p><p><strong>Methods: </strong>This study was a cross-sectional study. The corresponding IHC slides were selected from the pathology archive and examined by the pathologist. Fifty-one samples which showed both in situ and invasive components confirmed immunohistochemically, were included in the study.</p><p><strong>Results: </strong>In 70.6% of the cases a high grade of in situ and invasive carcinoma was observed. In 45.1% of the studied cases, a solid structure was observed in in-situ carcinoma, and no otherwise specified structure was observed in invasive carcinoma. In 74.5% of both in situ and invasive carcinoma types, ER.PR had a positive value. In 45.5% of the cases, both in situ and invasive carcinoma components show low Ki67. In 42.2%, both in situ and invasive carcinomas were Her2 negative. There was no significant difference between the grade (<i>P</i>=0.687), Her2 type (<i>P</i>=0.532), and structure (<i>P</i>=0.532). ER.PR (<i>P</i>=1.00) and Ki67 (<i>P</i>=0.180) of in situ and invasive carcinoma in this study.</p><p><strong>Conclusion: </strong>Our study showed differences between in situ and invasive biomarker expression. According to our findings, owing to heterogeneity, in situ components can't be representative of invasive components for treatment choices.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 3","pages":"318-325"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11646206/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142839673","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Breast Carcinoma Coexistent with Ipsilateral Axillary Non-Hodgkin Lymphoma: Cytological Diagnosis Aided with Cellblock Immunohistochemistry. 乳腺癌与同侧腋窝非霍奇金淋巴瘤并存:细胞学诊断辅以细胞块免疫组化。
Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-02-15 DOI: 10.30699/IJP.2024.2014737.3203
Krishnendu Mondal, Rupali Mandal
{"title":"Breast Carcinoma Coexistent with Ipsilateral Axillary Non-Hodgkin Lymphoma: Cytological Diagnosis Aided with Cellblock Immunohistochemistry.","authors":"Krishnendu Mondal, Rupali Mandal","doi":"10.30699/IJP.2024.2014737.3203","DOIUrl":"10.30699/IJP.2024.2014737.3203","url":null,"abstract":"","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 2","pages":"69-271"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11304454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907911","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparing Length and Telomere Expression at Oral Precancerous and Cancerous Stages. 比较口腔癌前病变和癌变阶段的长度和端粒表达。
Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-02-15 DOI: 10.30699/IJP.2024.1996330.3081
Fahad Mansoor Samadi, Shaista Suhail, Manjari Sonam, Mohd Kaleem Ahmad, Vijay Kumar, Shaleen Chandra, Shadab Mohammad

Background & objective: Telomeres consist of repetitive G-rich nucleotides located at the end of each chromosome, acting as protein binding sites. The aim of this study was to examine the differences in telomere length in blood, saliva, and tissue samples at various stages of oral precancerous and cancerous lesions.

Methods: Samples of blood, tissue, and saliva were collected from patients with oral precancerous and cancerous lesions. DNA extraction was performed. Then, a TRAP assay was conducted to assess and compare the telomere length and telomerase expression.

Results: The levels of telomerase activity (TA) in the DNA samples ranged from 0.19 to 6.91 (2.05+1.37) among oral squamous cell carcinoma (OSCC) patients and from 0.17 to 4.5 (0.28+4.25) among precancerous patients. A significant difference was observed in TA levels between OSCC and precancerous samples (t=3.9691, P= 0.0000).

Conclusion: Assessing the telomerase activity is crucial for studying the behavior of carcinoma in the clinical setting. The augmented telomerase expression and the length of telomere contribute to OSCC progression. Hence, this study adds a diagnostic tool that can serve as a biomarker for the early detection and prognosis of OSCC.

背景与目的:端粒由重复的富含G的核苷酸组成,位于每条染色体的末端,是蛋白质的结合位点。本研究旨在检测口腔癌前病变和癌症病变不同阶段的血液、唾液和组织样本中端粒长度的差异:方法:收集口腔癌前病变和癌症患者的血液、组织和唾液样本。进行 DNA 提取。结果:端粒酶活性(TRAP)、端粒长度(TRAP)和端粒长度(TRAP结果:在口腔鳞状细胞癌(OSCC)患者中,DNA样本中端粒酶活性(TA)的水平从0.19到6.91(2.05+1.37)不等;在癌前病变患者中,端粒酶活性(TA)的水平从0.17到4.5(0.28+4.25)不等。OSCC和癌前病变样本的端粒酶水平存在明显差异(t=3.9691,P=0.0000):评估端粒酶活性对于研究临床环境中的癌变行为至关重要。端粒酶表达的增强和端粒的长度有助于OSCC的进展。因此,这项研究为OSCC的早期检测和预后增加了一种可作为生物标志物的诊断工具。
{"title":"Comparing Length and Telomere Expression at Oral Precancerous and Cancerous Stages.","authors":"Fahad Mansoor Samadi, Shaista Suhail, Manjari Sonam, Mohd Kaleem Ahmad, Vijay Kumar, Shaleen Chandra, Shadab Mohammad","doi":"10.30699/IJP.2024.1996330.3081","DOIUrl":"10.30699/IJP.2024.1996330.3081","url":null,"abstract":"<p><strong>Background & objective: </strong>Telomeres consist of repetitive G-rich nucleotides located at the end of each chromosome, acting as protein binding sites. The aim of this study was to examine the differences in telomere length in blood, saliva, and tissue samples at various stages of oral precancerous and cancerous lesions.</p><p><strong>Methods: </strong>Samples of blood, tissue, and saliva were collected from patients with oral precancerous and cancerous lesions. DNA extraction was performed. Then, a TRAP assay was conducted to assess and compare the telomere length and telomerase expression.</p><p><strong>Results: </strong>The levels of telomerase activity (TA) in the DNA samples ranged from 0.19 to 6.91 (2.05+1.37) among oral squamous cell carcinoma (OSCC) patients and from 0.17 to 4.5 (0.28+4.25) among precancerous patients. A significant difference was observed in TA levels between OSCC and precancerous samples (<i>t</i>=3.9691, <i>P</i>= 0.0000).</p><p><strong>Conclusion: </strong>Assessing the telomerase activity is crucial for studying the behavior of carcinoma in the clinical setting. The augmented telomerase expression and the length of telomere contribute to OSCC progression. Hence, this study adds a diagnostic tool that can serve as a biomarker for the early detection and prognosis of OSCC.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 2","pages":"146-151"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11304464/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141907913","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive Analysis of the Prognostic Marker and Immune Infiltrates of LDLR-Related Proteins Family Members in Breast Cancer. 乳腺癌预后标志物和 LDLR 相关蛋白家族成员免疫渗透的综合分析
Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-03-29 DOI: 10.30699/IJP.2024.1995769.3077
Shabnam Shahidi, Parvin Ansari Shayesteh, Mahsa Alami, Negin Parsamanesh

Background & objective: Breast cancer (BC) is one of the most frequent tumors worldwide, accounting for 15% of all cancer-related deaths. A timely diagnosis of BC is essential for optimal treatment and increasing patients' survival rates. LRP family proteins are important components of cell-surface receptors involved in numerous biological activities. Expression of LRP is related to breast malignancy. In this study, we initially studied the expression of LRPs in BC tissues compared to normal tissues-the relation of LRP expression with relapse-free survival (RFS) and overall survival (OS). Then, we investigated the association of LRPs relation and immune infiltrating abundance.

Methods: We analyzed the LDLR family expression and prognostic value in BC by mining UALCAN, TIMER, and Kaplan-Meier plotter databases. Subsequently, we explored the association of LDLR expression and immune infiltrating abundance via the TIMER database.

Results: Expression levels of LRP1/2/4/9/10 were found to be higher in the cases with positive estrogen receptors. There was a positive association between LRP1/6 expression and the infiltration of CD8+ T cells, CD4+ T Cell, Macrophage, Dendritic Cell, and Neutrophil.

Conclusion: Our study recommends LDLR as a potential prognostic biomarker that can be promising to improve the survival of BC patients' survival. However, further investigations are needed to evaluate the studied LDLR members in more detail.

背景与目的:乳腺癌(BC)是全球最常见的肿瘤之一,占癌症相关死亡总数的 15%。及时诊断乳腺癌对优化治疗和提高患者生存率至关重要。LRP 家族蛋白是细胞表面受体的重要组成部分,参与多种生物活动。LRP 的表达与乳腺恶性肿瘤有关。在这项研究中,我们首先研究了与正常组织相比,LRP在乳腺癌组织中的表达--LRP表达与无复发生存率(RFS)和总生存率(OS)的关系。然后,我们研究了LRPs与免疫浸润丰度的关系:我们通过挖掘 UALCAN、TIMER 和 Kaplan-Meier plotter 数据库,分析了 LDLR 家族在 BC 中的表达和预后价值。随后,我们通过TIMER数据库探讨了LDLR表达与免疫浸润丰度的关联:结果:在雌激素受体阳性的病例中,LRP1/2/4/9/10的表达水平较高。LRP1/6的表达与CD8+ T细胞、CD4+ T细胞、巨噬细胞、树突状细胞和中性粒细胞的浸润呈正相关:我们的研究推荐LDLR作为一种潜在的预后生物标志物,有望改善BC患者的生存率。然而,还需要进一步的研究来更详细地评估所研究的 LDLR 成员。
{"title":"Comprehensive Analysis of the Prognostic Marker and Immune Infiltrates of LDLR-Related Proteins Family Members in Breast Cancer.","authors":"Shabnam Shahidi, Parvin Ansari Shayesteh, Mahsa Alami, Negin Parsamanesh","doi":"10.30699/IJP.2024.1995769.3077","DOIUrl":"10.30699/IJP.2024.1995769.3077","url":null,"abstract":"<p><strong>Background & objective: </strong>Breast cancer (BC) is one of the most frequent tumors worldwide, accounting for 15% of all cancer-related deaths. A timely diagnosis of BC is essential for optimal treatment and increasing patients' survival rates. LRP family proteins are important components of cell-surface receptors involved in numerous biological activities. Expression of LRP is related to breast malignancy. In this study, we initially studied the expression of LRPs in BC tissues compared to normal tissues-the relation of LRP expression with relapse-free survival (RFS) and overall survival (OS). Then, we investigated the association of LRPs relation and immune infiltrating abundance.</p><p><strong>Methods: </strong>We analyzed the LDLR family expression and prognostic value in BC by mining UALCAN, TIMER, and Kaplan-Meier plotter databases. Subsequently, we explored the association of LDLR expression and immune infiltrating abundance via the TIMER database.</p><p><strong>Results: </strong>Expression levels of LRP1/2/4/9/10 were found to be higher in the cases with positive estrogen receptors. There was a positive association between LRP1/6 expression and the infiltration of CD8+ T cells, CD4+ T Cell, Macrophage, Dendritic Cell, and Neutrophil.</p><p><strong>Conclusion: </strong>Our study recommends LDLR as a potential prognostic biomarker that can be promising to improve the survival of BC patients' survival. However, further investigations are needed to evaluate the studied LDLR members in more detail.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 1","pages":"31-49"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11164315/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141306996","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Delving into the Role of α-Smooth Muscle Actin as a Predictive Biomarker of Early Recurrence in Invasive Ductal Adenocarcinoma of Breast. α-平滑肌肌动蛋白在乳腺浸润性导管腺癌早期复发预测中的作用
Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-07-15 DOI: 10.30699/IJP.2024.2022442.3255
Seetu Palo
{"title":"Delving into the Role of α-Smooth Muscle Actin as a Predictive Biomarker of Early Recurrence in Invasive Ductal Adenocarcinoma of Breast.","authors":"Seetu Palo","doi":"10.30699/IJP.2024.2022442.3255","DOIUrl":"10.30699/IJP.2024.2022442.3255","url":null,"abstract":"","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 3","pages":"363-364"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11646196/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142839821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Most Common Multi-Drug Resistant Bacteria Associated with Hospital Infections, in Urmia, Iran. 在伊朗乌尔米亚与医院感染相关的最常见多重耐药细菌
Q3 Medicine Pub Date : 2024-01-01 Epub Date: 2024-07-24 DOI: 10.30699/IJP.2024.2014294.3195
Seyyed Jalil Mousavi, Rahim Nezhadrahim, Farima Abdulzadeh

Background & objective: Hospital-acquired infections (HAIs) are a major healthcare problem in hospitalized patients, especially in developing countries, where they affect millions of patients and cause high mortality rates. This study aimed to investigate multidrug-resistant bacterial strains in NIs at Imam Khomeini University Hospital in Urmia, Iran.

Methods: This cross-sectional study was conducted using a convenience sampling method. The study population comprised all positive clinical samples from HAIs registered in the laboratory of Imam Khomeini Hospital, Urmia, Iran, in 2019. Bacteria were identified by culturing the samples on blood agar and MacConkey agar, followed by performing standard biochemical tests. Antibiotic susceptibility testing was carried out using the disk diffusion method, in accordance with CLSI guidelines.

Results: Of the 607 positive samples, the most common microorganisms isolated were Escherichia coli (27.5%), Acinetobacter baumannii (18.5%), and Klebsiella pneumoniae (15.2%). The distribution of resistance to the number of antibiotics in bacterial isolates from the samples showed that 19.8% of them were resistant to one antibiotic and 13.2% were resistant to three antibiotics. 40.5% of the samples showed no resistance to antibiotics.

Conclusion: This study highlights the critical issue of HAIs and the prevalence of multidrug-resistant bacteria in Urmia, Iran. Urgent measures, including improved hygiene, accurate diagnostics, appropriate antibiotic use, and stakeholder education, are essential. Establishing a robust HAI surveillance system is also recommended. Future efforts should aim at understanding and mitigating the spread of these pathogens.

背景和目的:医院获得性感染(HAIs)是住院病人的主要医疗问题,尤其是在发展中国家,数百万病人受到影响,死亡率很高。本研究旨在调查伊朗乌尔米耶市伊玛目霍梅尼大学医院的耐多药细菌菌株:这项横断面研究采用方便抽样法。研究对象包括 2019 年在伊朗乌尔米耶伊玛目霍梅尼医院实验室登记的所有 HAIs 阳性临床样本。通过在血琼脂和麦康凯琼脂上培养样本,然后进行标准生化测试来鉴定细菌。根据 CLSI 指南,采用盘扩散法进行抗生素敏感性检测:结果:在 607 份阳性样本中,最常见的分离微生物是大肠埃希菌(27.5%)、鲍曼不动杆菌(18.5%)和肺炎克雷伯菌(15.2%)。从样本中分离出的细菌对多种抗生素的耐药性分布显示,19.8%的细菌对一种抗生素耐药,13.2%的细菌对三种抗生素耐药。40.5%的样本对抗生素没有耐药性:本研究强调了伊朗乌尔米耶市人感染感染和耐多药细菌流行的严重问题。必须采取紧急措施,包括改善卫生条件、准确诊断、合理使用抗生素以及开展利益相关者教育。此外,还建议建立健全的 HAI 监控系统。今后的工作应着眼于了解和减少这些病原体的传播。
{"title":"The Most Common Multi-Drug Resistant Bacteria Associated with Hospital Infections, in Urmia, Iran.","authors":"Seyyed Jalil Mousavi, Rahim Nezhadrahim, Farima Abdulzadeh","doi":"10.30699/IJP.2024.2014294.3195","DOIUrl":"10.30699/IJP.2024.2014294.3195","url":null,"abstract":"<p><strong>Background & objective: </strong>Hospital-acquired infections (HAIs) are a major healthcare problem in hospitalized patients, especially in developing countries, where they affect millions of patients and cause high mortality rates. This study aimed to investigate multidrug-resistant bacterial strains in NIs at Imam Khomeini University Hospital in Urmia, Iran.</p><p><strong>Methods: </strong>This cross-sectional study was conducted using a convenience sampling method. The study population comprised all positive clinical samples from HAIs registered in the laboratory of Imam Khomeini Hospital, Urmia, Iran, in 2019. Bacteria were identified by culturing the samples on blood agar and MacConkey agar, followed by performing standard biochemical tests. Antibiotic susceptibility testing was carried out using the disk diffusion method, in accordance with CLSI guidelines.</p><p><strong>Results: </strong>Of the 607 positive samples, the most common microorganisms isolated were <i>Escherichia coli</i> (27.5%), <i>Acinetobacter baumannii</i> (18.5%), and <i>Klebsiella pneumoniae</i> (15.2%). The distribution of resistance to the number of antibiotics in bacterial isolates from the samples showed that 19.8% of them were resistant to one antibiotic and 13.2% were resistant to three antibiotics. 40.5% of the samples showed no resistance to antibiotics.</p><p><strong>Conclusion: </strong>This study highlights the critical issue of HAIs and the prevalence of multidrug-resistant bacteria in Urmia, Iran. Urgent measures, including improved hygiene, accurate diagnostics, appropriate antibiotic use, and stakeholder education, are essential. Establishing a robust HAI surveillance system is also recommended. Future efforts should aim at understanding and mitigating the spread of these pathogens.</p>","PeriodicalId":38900,"journal":{"name":"Iranian Journal of Pathology","volume":"19 3","pages":"283-291"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11646194/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142839861","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Iranian Journal of Pathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1